Comparing Different Doses of Corticosteroids in Local Infiltration Analgesia (LIA) for Total Knee Arthroplasty

Recruiting now · Not applicable

Conditions studied: Adrenal Cortex Hormones, Arthroplasty, Replacement, Knee, Anesthesia, Local

In brief

This study aims to compare the efficacy of different doses of glucocorticoids in local infiltration analgesia (LIA) during total knee arthroplasty (TKA) through a prospective single-center randomized controlled trial, and to explore the safety and feasibility of high-dose glucocorticoids. Through this research, the investigators hope to provide an optimized solution for post-TKA pain management, improve patients' postoperative recovery and quality of life, and offer scientific evidence for pain management following TKA.

Key facts

Study ID

NCT07337772

Run by

First Affiliated Hospital of Fujian Medical University

People needed

120

Starts

2026-02-01

Expected to finish

2028-11-01

Last updated by the study team

2026-01-13

Who can join

Age: 18 and older, up to 100. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male or female participants aged 18 years or older;
• Undergoing primary unilateral total knee arthroplasty (TKA)for unilateral knee osteoarthritis(OA)at ourhospital;
• Preoperative American Society of Anesthesiologists(ASA)physical status classification of 1-3;
• Ability to provide informed consent and sign a written informed consent form.

You may not qualify if…

• Previous surgery on the operative knee or a history of infection in the operative knee;
• Non-osteoarthritis conditions (including rheumatoid arthritis, traumatic arthritis, septic arthritis, and hemophilic arthritis);
• Severe osteoarthritis (including flexion contracture >30° or varus/valgus deformity >30°);
• Allergy to the relevant study drugs;
• Presence of neuromuscular dysfunction in the ipsilateral limb;
• Dependence on anesthetic drugs (defined as weekly use of opioids exceeding 100 mg morphine equivalents or local anesthetics for preoperative pain control for more than 3 months);
• Poor systemic condition, including but not limited to: glycated hemoglobin (HbA1c) level >12%; blood pressure >170/110 mmHg (1 mmHg = 0.133 kPa); history of myocardial infarction, stroke, transient ischemic attack, acute congestive heart failure, or any acute coronary event within 6 months; dialysis or renal transplantation; pregnancy or lactation.

Where it is running

• The First Affiliated Hospital of Fujian Medical University — Fuzhou, Fujian, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.